This activity is based on the slides and lectures presented as an official Satellite Symposium held in conjunction with the American Academy of Pain Medicine (AAPM) 25th Annual Meeting on January 28, 2009

CME OPPOrtunity!

Current treatment Landscape and Emerging Management Options for Breakthrough Pain in Patients with CancerTo participate in this activity (valid from April 1, 2009 though April 1, 2010) please visit: http://www.medscapecme.com/lecture/btp PrOGrAM DESCriPtiOnin this on-demand program, the pathophysiology and characteristics of Breakthrough pain in patients with cancer, its prevalence, and the negative impact on patients will be reviewed. the importance of treating Breakthrough pain as a separate entity from baseline pain and treatment goals will be discussed. Current treatments will be explored, as well as new therapeutic options that may have faster onset of activity, greater flexibility in terms of dosing, and fewer side effects.

In order to achieve credit, you must complete the on-line post test and evaluation. Credit for this

activity will be available from April 1, 2009 through

April 1, 2010

Please participate in an on-demand webcast. Complimentary!

FACuLtyBill H. McCarberg, MDAdjunct Assistant Clinical Professor, University of California, San DiegoFounder, Chronic Pain Management Program, Kaiser PermanenteSan Diego, California

Bruce Nicholson, MDClinical Associate Professor of Anesthesia, Penn State School of Medicine Hershey, PennsylvaniaDirector of the Division of Pain Medicine, Lehigh Valley Hospital and Health NetworkAllentown, Pennsylvania

Lynn R. Webster, MD, FACPM, FASAM Medical Director, Lifetree Clinical Research & Pain ClinicSalt Lake City, utah

this program is supported by an educational grant from MEDA pharmaceuticals with ACCME standards

Current treatment Landscape and Emerging Management Options for Breakthrough Pain in Patients with CancertArGEt AuDiEnCE:this CME activity is intended for practicing physicians, nurses, and other health care professionals who have an interest in Breakthrough pain in Cancer Pain management.

EDuCAtiOnAL OBJECtivES:At the conclusion of this activity, participants should be able to: · Describe the pathophysiology and characteristics of Breakthrough pain in Cancer Patients, its prevalence, and the negative impact on patients· Discuss the importance of treating Breakthrough pain in Cancer Patients as a separate entity from baseline pain and treatment goals· Evaluate current treatments and investigational agents· Assess the risks/benefits of therapy· Identify how to tailor treatment to individual needs of patients and minimize risks and maximize clinical outcomes

Accreditation Statement:Physician Credit: this activity has been reviewed and is acceptable for up to 2 prescribed credits by the American Academy of Family Physicians.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PrA Category 1 Credit toward the AMA Physician’s recognition award. When applying for the AMA PrA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.

Nursing Credit: Educational review Systems is an approved provider of continuing education in nursing by ASnA, an accredited provider by the AnCC/Commission on Accreditation. Provider # 5-115-09-019. this program is approved for 2 hour of continuing nursing education.

Educational review Systems is also approved for nursing continuing education by the state of California and the District of Columbia

it is the policy of Educational review Systems (ErS) that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). ErS will resolve all conflicts of interest prior to this educational activity.

401 S. Florida Avetampa, FL 33602

To participate in this activity (valid from April 1, 2009 though April 1, 2010) please visit: http://www.medscapecme.com/lecture/btp